ATE485255T1 - Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung - Google Patents

Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung

Info

Publication number
ATE485255T1
ATE485255T1 AT02746039T AT02746039T ATE485255T1 AT E485255 T1 ATE485255 T1 AT E485255T1 AT 02746039 T AT02746039 T AT 02746039T AT 02746039 T AT02746039 T AT 02746039T AT E485255 T1 ATE485255 T1 AT E485255T1
Authority
AT
Austria
Prior art keywords
reduced coenzyme
aqueous solution
crystallizing reduced
crystallizing
coenzyme
Prior art date
Application number
AT02746039T
Other languages
English (en)
Inventor
Takahiro Ueda
Shiro Kitamura
Yasuyoshi Ueda
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Application granted granted Critical
Publication of ATE485255T1 publication Critical patent/ATE485255T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/34Separation; Purification; Stabilisation; Use of additives
    • C07C41/40Separation; Purification; Stabilisation; Use of additives by change of physical state, e.g. by crystallisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AT02746039T 2001-07-13 2002-07-15 Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung ATE485255T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001214477 2001-07-13
JP2002114874 2002-04-17
PCT/JP2002/007146 WO2003006411A1 (fr) 2001-07-13 2002-07-15 Procede de cristallisation d'une coenzyme q10 reduite a partir d'une solution aqueuse

Publications (1)

Publication Number Publication Date
ATE485255T1 true ATE485255T1 (de) 2010-11-15

Family

ID=26618742

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02746039T ATE485255T1 (de) 2001-07-13 2002-07-15 Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung

Country Status (10)

Country Link
US (1) US20040197886A1 (de)
EP (1) EP1408024B1 (de)
JP (1) JP4116540B2 (de)
KR (1) KR20040018456A (de)
CN (1) CN1266102C (de)
AT (1) ATE485255T1 (de)
AU (1) AU2002318846B2 (de)
CA (1) CA2453164A1 (de)
DE (1) DE60238056D1 (de)
WO (1) WO2003006411A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI329510B (en) * 2001-10-10 2010-09-01 Kaneka Corp Method of stabilizing reduced coenzyme q10
TWI305547B (en) 2001-12-27 2009-01-21 Kaneka Corp Processes for producing coenzyme q10
KR20050101170A (ko) * 2003-01-10 2005-10-20 가부시키가이샤 가네카 환원된 조효소 q10의 정제 방법
US7358402B2 (en) * 2003-09-10 2008-04-15 Kaneka Corporation Reduced coenzyme Q10 crystal with excellent stability and composition containing said reduced coenzyme Q10 crystal
US20060147542A1 (en) * 2004-12-24 2006-07-06 Tadao Ono Solid preparation containing reduced coenzyme Q10 and method for producing the same
US8067217B2 (en) * 2004-12-28 2011-11-29 Kaneka Corporation Method for preserving reduced coenzyme Q10
WO2007126086A1 (ja) * 2006-04-28 2007-11-08 Kaneka Corporation 還元型補酵素q10の精製方法
WO2008084828A1 (ja) * 2007-01-11 2008-07-17 Kaneka Corporation 補酵素q10粒子の製造方法
DK2725004T3 (en) 2011-06-24 2018-04-16 Kaneka Corp REDUCED COENZYM Q10 CRYSTAL WITH EXCELLENT STABILITY
JP2015131766A (ja) * 2012-04-27 2015-07-23 株式会社カネカ 還元型補酵素q10の製造方法
WO2020029017A1 (en) 2018-08-06 2020-02-13 Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. Systems and methods for producing coenzyme q10
CN112839921B (zh) * 2018-08-30 2024-02-20 株式会社钟化 稳定性优异的还原型辅酶q10结晶的制造方法
WO2022202215A1 (ja) * 2021-03-26 2022-09-29 株式会社カネカ FormII型の還元型補酵素Q10結晶又はその結晶性固体の製造方法及び晶析装置

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1883952A (en) * 1932-10-25 Sobation of new yobk
US2205096A (en) * 1937-03-19 1940-06-18 Union Oil Co Process for separating wax from wax-oil mixtures
US2560193A (en) * 1947-12-27 1951-07-10 Standard Oil Co Dehazing hydrocarbon oils
GB947643A (en) 1959-05-25 1964-01-22 Merck & Co Inc Substituted chroman compounds
US3066080A (en) * 1961-03-22 1962-11-27 Merck & Co Inc Fermentation production of coenzyme q-10
JPS5915894B2 (ja) * 1975-12-15 1984-04-12 ニツシンセイフン カブシキガイシヤ ホコウソqノセイゾウホウホウ
US4220747A (en) * 1976-06-28 1980-09-02 Allied Chemical Corporation Crystalline diacetylene polymers
JPS5692238A (en) * 1979-12-26 1981-07-25 Ajinomoto Co Inc Separation and recovery of hydroquinone derivative
JP3889481B2 (ja) * 1996-08-16 2007-03-07 株式会社カネカ 医薬組成物
JPH1085502A (ja) * 1996-09-19 1998-04-07 Konica Corp 晶析方法
AT408226B (de) * 1999-05-05 2001-09-25 Biochemie Gmbh Kristalliner 7-(2-(2-formylaminothiazol-4-yl)-2
US6740338B1 (en) * 2000-01-20 2004-05-25 Raj K. Chopra Reduced form of Cenzyme Q in high bioavailability stable oral dosage form
US20020061888A1 (en) * 2000-03-10 2002-05-23 Keller Bradley T. Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders

Also Published As

Publication number Publication date
EP1408024A4 (de) 2006-02-01
WO2003006411A1 (fr) 2003-01-23
EP1408024A1 (de) 2004-04-14
CN1266102C (zh) 2006-07-26
DE60238056D1 (de) 2010-12-02
JPWO2003006411A1 (ja) 2004-11-04
AU2002318846A2 (en) 2003-01-29
EP1408024B1 (de) 2010-10-20
US20040197886A1 (en) 2004-10-07
JP4116540B2 (ja) 2008-07-09
AU2002318846B2 (en) 2008-06-12
CN1551862A (zh) 2004-12-01
KR20040018456A (ko) 2004-03-03
CA2453164A1 (en) 2003-01-23

Similar Documents

Publication Publication Date Title
DK1182261T3 (da) Fremgangsmåde til frembringelse af basisk aminosyre
ATE485255T1 (de) Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung
DE50115863D1 (de) Verfahren zur regelung der fahrstabilität
DE50307242D1 (de) Verfahren zum herstellen von einkristallinen strukturen
DE10197144T1 (de) Verfahren zur Herstellung von Nitrilverbindungen aus ethylenisch ungesättigten Verbindungen
DE60117033D1 (de) Verfahren zur hydrocyanierung von äthylenisch ungesättigten organischen verbindungen
DE602004024402D1 (de) Verfahren zur herstellung von tetrazolderivaten au
DE60330746D1 (de) Integriertes Verfahren zur selektiven Oxydation von organischen Verbindungen
DE602004022429D1 (de) Verfahren zur hydrocyanierung von ungesättigten carbonsäure-derivaten
DE60215867D1 (de) Verfahren zur herstellung von penamderivaten aus cephamderivaten
EP1829868A4 (de) Verfahren zur herstellung von (4,5-dihydroxyisoxazol-3-yl)thiocarboxamidinsalzen
DE60239286D1 (de) Verfahren zur herstellung von trans-1,4-cyclohexandicarbonsäure
DE60336822D1 (de) Verfahren zur herstellung von kristallinem 1,2-polybutadien
DE60301019D1 (de) Verfahren zur Stabilierung sauerer Milchgetränke
ATE413867T1 (de) Methode zur behandlung von bewegungsstörungen mit barbitursäure derivaten.
ATE374757T1 (de) Verfahren zur herstellung von (1,4,5)- oxadiazepinderivaten
ATE274599T1 (de) Verfahren zur enzymatischen racematspaltung von aminomethyl-aryl-cyclohexanol-derivaten
DE60316011D1 (de) Verfahren zur herstellung von 3-methylthiopropanal
EP1392444A4 (de) Verfahren zur sulfidkonzentration
DE60322872D1 (de) Verfahren zur herstellung von säuresalzen von gemifloxacin
DE60316953D1 (de) Verfahren zur kontrolle von haarballen
DE60323991D1 (de) Verfahren zur herstellung von aldehydverbindungen
DE60302911D1 (de) Verfahren zur Herstellung von Alkyl-Harnstoffen aus O,S-Dimethyl-dithiocarbonaten
AU2003264143A1 (en) Method for determining the oxygen requirement of an aqueous solution for a purification process
DK1682476T3 (da) Fremgangsmåde til fremstilling af myresyreformiater

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties